CORDIS · 101158832 · HORIZON
RadExIORSBoost Twinning to skyrocket scientific excellence towards individual radiosensitivity prediction by raising the bar in knowledge transfer, networking, and technological innovation in radiobiology
Coordinator: INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE (RS)
Prostate cancer patients receiving radiotherapy (RT) may develop radiation-induced side effects, which significantly impact quality of life. One of the main challenges in radiobiology is to predict individual patient's normal tissue radiosensitivity to tailor personalized RT. Although the Institute for Oncology and Radiology of Serbia (IORS) is a highly specialized health, scientific, and educational institution it is necessary to develop a strategic action plan and sustainable knowledge transfer networking with top-class leading European institutions. Through the 6 Specific Objectives, RadEx…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
The project runs over approximately 3 years from 2024-10-01 to 2027-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from RS
see all →- CROSS-REIS — CROSS-disciplinary network for research excellence in Regenerative Economy Innovation eco-Systems101136834 · HORIZON · €4.4M
- EINSTEIN — EXCELLENCE INITIATIVE FOR NUTRIFOOD-BASED THERANOSTICS FOR HEALTHY EUROPEAN SOCIETY101136377 · HORIZON · €3.9M
- SENSEIVER — Low-cost and energy-efficient LTCC sensor/IR-UWB transceiver solutions for sustainable healthy environment289481 · FP7 · €3.0M
- INNOSENSE — Reinforcement of BioSense Center – ICT for Sustainability and Eco-Innovation316191 · FP7 · €2.6M
- HEROMAT — PROTECTION OF CULTURAL HERITAGE OBJECTS WITH MULTIFUNCTIONAL ADVANCED MATERIALS282992 · FP7 · €2.6M
- HIP-2D-QM — HIDDEN PHASES IN 2D-QUANTUM MATERIALS101185375 · HORIZON · €2.5M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2023-ACCESS-02.
- Who coordinates the project?
- The project is coordinated by INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE (RS).
- What is the project timeline?
- The project runs from 2024-10-01 to 2027-09-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101158832.